Conceptio
›
multiple-myeloma
Topic
multiple-myeloma
Knowledge-graph topic
· documents ABOUT multiple-myeloma across the archive
675
Documents about multiple-myeloma
Documents about multiple-myeloma
A Study to Evaluate the Safety of Empliciti® (Elotuzumab) When Treating Patients With Multiple Myeloma in Taiwan
#831620
ClinicalTrials.gov
Non-interventional Study With Pomalidomide (Imnovid®)
#834270
ClinicalTrials.gov
UARK 89-001 Phase II Study of Intensive "TOTAL THERAPY" For Untreated or Minimally Treated Patients With Multiple Myeloma
#844094
ClinicalTrials.gov
A Study of MLN9708 in Japanese Participants With Relapsed and/or Refractory Multiple Myeloma (RRMM)
#853380
ClinicalTrials.gov
Carfilzomib, Pegylated Liposomal Doxorubicin Hydrochloride, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma
#860318
ClinicalTrials.gov
Fixed Duration vs Continuous Anti-CD38 Antibody Therapy Among Transplant Ineligible Older Adults With Newly-Diagnosed Multiple Myeloma
#883646
ClinicalTrials.gov
Testing the Addition of Ixazomib/Placebo to Lenalidomide in Patients With Evidence of Residual Multiple Myeloma, OPTIMUM Trial
#888410
ClinicalTrials.gov
A Study Evaluating the Pharmacokinetics, Safety, and Efficacy of Cevostamab in Chinese Participants With Relapsed or Refractory Multiple Myeloma
#901024
ClinicalTrials.gov
Observational Study to Evaluate Hematopoietic Progenitor Cell Mobilization in Patients With Newly Diagnosed Multiple Myeloma
#917418
ClinicalTrials.gov
CAR19-BCMA Dual-target CAR-T in the Treatment of Relapsed / Refractory Multiple Myeloma
#966723
ClinicalTrials.gov
YTS104 Cell Injection for the Treatment of Relapsed or Refractory Multiple Myeloma
#969575
ClinicalTrials.gov
Tivantinib in Treating Patients With Relapsed, or Relapsed and Refractory Multiple Myeloma
#833357
ClinicalTrials.gov
A Study of Venetoclax Plus Lenalidomide and Dexamethasone for the Treatment of Newly Diagnosed t(11;14)-Positive Multiple Myeloma in Subjects Who Are Ineligible for High-Dose Therapy
#862660
ClinicalTrials.gov
Japan Expansion Cohort: Evaluation of Efficacy and Safety of Belantamab Mafodotin, Bortezomib and Dexamethasone Versus Daratumumab, Bortezomib and Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma
#891772
ClinicalTrials.gov
Dexamethasone, Elotuzumab, and Pomalidomide in Treating Patients With Refractory Multiple Myeloma
#356475
ClinicalTrials.gov
Assessing Free Immunoglobulin Light Chains in Patients With Myeloma
#884674
ClinicalTrials.gov
Home Based Daratumumab Administration for Patients With Multiple Myeloma
#967281
ClinicalTrials.gov
Bortezomib and High-dose Melphalan at Myeloma Relapse
#851622
ClinicalTrials.gov
The Burden of Multiple Myeloma on Patients and Caregivers Quality of Life: a Canadian Real-World Study
#871078
ClinicalTrials.gov
Use of Thalidomide, Lenalidomide, Carfilzomib, Bortezomib and Vorinostat in the Initial Treatment of Newly Diagnosed Multiple Myeloma Patients
#878682
ClinicalTrials.gov
A Study of Fully Human BCMA CAR-T (CT103A) in Patients With Newly Diagnosed High-risk Multiple Myeloma (FUMANBA-2)
#162451
ClinicalTrials.gov
A Feasibility and Safety Study of Dual Specificity CD38 and BCMA CAR-T Cell Immunotherapy for Relapsed or Refractory Multiple Myeloma
#366611
ClinicalTrials.gov
Bortezomib Pharmacogenetic Biomarkers for the Treatment of Multiple Myeloma: Review and Future Perspectives
#376167
Repositorio Institucional de la Universidad de Burgos (RIUBU)
To Assess the Safety and Tolerability of INCB000928 in Participants With Myelodysplastic Syndromes or Multiple Myeloma
#830457
ClinicalTrials.gov
Oprozomib and Dexamethasone,in Combination With Lenalidomide or Oral Cyclophosphamide to Treat Newly Diagnosed Multiple Myeloma
#840636
ClinicalTrials.gov
Selinexor and Backbone Treatments of Multiple Myeloma Patients
#841205
ClinicalTrials.gov
Study of Elotuzumab in Combination With Lenalidomide and Dexamethasone in Subjects With Multiple Myeloma and Various Levels of Renal Function
#844550
ClinicalTrials.gov
Dara-PD in the Treatment of Patients With First Relapse of Multiple Myeloma
#857959
ClinicalTrials.gov
Pomalidomide and Dexamethasone With or Without Ixazomib in Treating Patients With Relapsed Multiple Myeloma
#896130
ClinicalTrials.gov
Safety and Efficacy of IM21 Car-t Cells in Patients With Recurrent or Refractory BCMA Positive Multiple Myeloma
#967446
ClinicalTrials.gov
Dose Escalation Trial of Dalotuzumab (MK-0646) in Advanced Solid Tumors and Multiple Myeloma (MK-0646-001)
#994119
ClinicalTrials.gov
Once weekly versus twice weekly carfilzomib dosing in patients with relapsed and refractory multiple myeloma (A.R.R.O.W.): interim analysis results of a randomised, phase 3 study
#296806
Gestión del Repositorio Documental de la Universidad de Salamanca
Metformin, Nelfinavir, and Bortezomib in Treating Patients With Relapsed and/or Refractory Multiple Myeloma
#230389
ClinicalTrials.gov
An Expanded Treatment Protocol of Panobinostat in Combination Therapy for Relapsed, and Relapsed and Refractory Multiple Myeloma
#842852
ClinicalTrials.gov
A Clinical Study to Evaluate the Safety and Preliminary Efficacy of QI-019A in Patients With Relapsed/Refractory Multiple Myeloma.
#882990
ClinicalTrials.gov
Dendritic Cells(DC)-Based Id Vaccination in Stage-I Myeloma
#238132
ClinicalTrials.gov
ATRA and Carfilzomib in Plasma Cell Myeloma Patients
#854552
ClinicalTrials.gov
Daratumumab in Treating Patients With Multiple Myeloma
#869101
ClinicalTrials.gov
Cardiovascular Complications of Carfilzomib Treatment
#217145
ClinicalTrials.gov
Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Lemzoparlimab With or Without Oral/IV Dexamethasone and in Combination With Oral/IV/Subcutaneous Anti-Myeloma Regimens in Adult Participants With Multiple Myeloma
#843176
ClinicalTrials.gov
Risk of adverse events in elotuzumab-treated patients with multiple myeloma: a systematic review and meta-analysis
#4563
Europe PMC
Disrupting USP39 deubiquitinase function impairs the survival and migration of multiple myeloma cells through ZEB1 degradation
#215399
HAL (France)
Filanesib (ARRY-520) in Combination With Pomalidomide and Dexamethasone for Relapsed/Refractory (R/R) Multiple Myeloma (MM) Patients
#827771
ClinicalTrials.gov
BCMA Nano Antibody CAR-T Cells for Patients With Refractory and Relapsed Multiple Myeloma
#827806
ClinicalTrials.gov
Study of Novel Regimens in Relapsed or Refractory Multiple Myeloma
#830778
ClinicalTrials.gov
Consolidation Therapy With Bortezomib in Elderly Patients With Multiple Myeloma
#840510
ClinicalTrials.gov
Carfilzomib in Treatment Patients Under 65 Years With High Risk Smoldering Multiple Myeloma
#861158
ClinicalTrials.gov
Impact of Budesonide on Incidence of ≥ Gr2 Diarrhea in Multiple Myeloma (MM) Patients Undergoing Autologous Stem Cell Transplant
#871766
ClinicalTrials.gov
Evaluation of Ultrasensitive Chromosomal Aneuploidy Detection for Detecting Minimal Residual Disease in Multiple Myeloma
#878166
ClinicalTrials.gov
A Study of Ixazomib (NINLARO®) in Combination With Lenalidomide and Dexamethasone (IRD) for the Treatment of Participants With Multiple Myeloma (MM)
#887333
ClinicalTrials.gov
← Previous
Page 8 of 20
Next →
Topic record
· derived from the Conceptio knowledge graph (shared subject terms across the corpus)
Conceptio Open Knowledge Archive — topic hubs link to canonical document pages with full provenance.